Palmitoyl Tetrapeptide-20 (PTP20) is supplied in different commercial forms - most commonly a raw powder, a pre-diluted solution, or a branded complex. The choice affects active-content control, handling, storage, testing and total cost, and it should be made on the basis of the exact supplied specification rather than habit. This guide compares powder and solution for hair-care formulation and explains how B2B buyers should evaluate both. For background on the ingredient, see What Is Palmitoyl Tetrapeptide-20?. For the mechanism behind its use in hair pigmentation research, see How Does Palmitoyl Tetrapeptide-20 Work?
Quick Comparison
| Comparison Point | Powder | Solution |
|---|---|---|
| Active peptide concentration | Usually higher; confirm assay | May be ppm-level or percentage concentrate; confirm active basis |
| Formulation flexibility | Higher | Carrier system largely predefined |
| Handling | Requires accurate weighing | Often easier for low-dose addition |
| Carrier | Selected by formulator | Predefined by supplier |
| Shipping | Less carrier volume per active unit | More carrier volume per active unit |
| Microbial considerations | Depends on supplied dry material and storage | Aqueous systems require appropriate microbial control |
| Cost comparison | Compare on active-peptide basis | Compare on active-peptide basis |
None of these points is absolute. The right form depends on production scale, analytical capability, the target product and the supplier's documented specification.
When Should a Formulator Choose Powder?
Powder suits organizations that can control the full formulation chain:
- In-house R&D capability - a laboratory that can weigh accurately, prepare stock solutions and verify content.
- Control over the carrier system - the formulator decides whether the final base is water, a glycerin blend or another vehicle.
- Multiple concentrations across products - one powder can serve different use levels, whereas a solution locks in one concentration.
- Larger production batches - when active consumption is high, powder minimizes shipping weight, carrier cost and container volume.
- Analytical capability - access to HPLC or assay verification makes powder manageable and auditable.
Powder is not a shortcut: it demands precise dosing, and the peptide content (assay) rather than bottle weight must drive the weigh-out. If the team cannot verify or control these parameters, powder may introduce more risk than convenience.
When Is a Solution More Practical?
A pre-diluted solution can be the faster route in specific situations:
- Rapid prototyping - a solution can be added directly to the water phase for quick formula trials.
- Small-scale production - where micro-weighing a low-dose peptide is impractical.
- No precision weighing equipment - volume-based dosing is easier for operators without analytical balances.
- Defined carrier system - the peptide is supplied in a pre-formulated vehicle, reducing the need for the buyer to develop the initial dissolution system from raw powder.
The trade-off is concentration and transparency. A solution's active peptide concentration may be very low because of carriers such as water and glycerin, so the amount needed per batch is larger, and the cost per gram of active peptide may differ substantially. The active basis must always be recalculated from the supplier specification - never assumed from the bottle weight or from a branded name. See the PTP20 formulation guide for how to calculate active content in a real formula.
How to Compare Prices Correctly
Comparing "price per kilogram of powder" with "price per kilogram of solution" is misleading, because the two forms contain very different amounts of active peptide. The correct unit is:
Cost per gram of active peptide = Material price per kilogram ÷ Active peptide grams per kilogram
where Active peptide grams per kilogram = 1000 × assay fraction.
For example, an 85% assay powder contains 850 g of active peptide per kilogram, while a 0.5% solution contains only 5 g per kilogram. Therefore, buyers should compare supplier quotations on an active-peptide basis rather than simply comparing price per kilogram of supplied material.
Is Every PTP20 Solution the Same?
No. "Palmitoyl Tetrapeptide-20 solution" describes a category, not a single material. Buyers should verify:
- Peptide identity - generic Palmitoyl Tetrapeptide-20, Palmitoyl Tetrapeptide-20 Amide and branded complexes such as Greyverse™ (listed INCI: Glycerin (and) Water (and) Palmitoyl Tetrapeptide-20 Amide) are not interchangeable materials.
- Terminal form - amide or free-acid, which affects the specification and possibly the behavior.
- Active concentration - the assay basis and how it is measured.
- Carrier composition - water, glycerin, other solvents and their percentages.
- Preservative system - required for aqueous solutions; confirm type and level.
- pH - should be stated on the TDS.
- Country-specific INCI - INCI listings can differ by market.
- Branded blend vs generic material - a branded complex may carry its own formulation and data package, which should not be automatically attributed to a generic solution.
A solution made from one PTP20-type material should not be assumed to work in a formula built for another. Confirm identity and specification before comparing suppliers.
Documents Buyers Should Request
For any PTP20 form - powder or solution - request the following documentation before purchase:
- Batch-specific COA
- HPLC chromatogram
- MS identity report
- Peptide assay (active basis)
- Technical data sheet (TDS)
- Material safety data sheet (MSDS)
- Stability data
- Microbiological specification
- Residual solvent information
- Allergen / GMO statements (where applicable)
- Manufacturing and traceability statement
A supplier that cannot provide batch-level documentation for a peptide raw material should be treated as a red flag.
What Should Buyers Compare Between Powder and Solution Suppliers?
Practical screening questions for B2B buyers:
- Does the supplier state the peptide sequence and terminal form explicitly?
- Does the supplier distinguish HPLC purity from active peptide content (assay)?
- Are batch-specific COA, HPLC and MS reports available?
- Is batch-to-batch consistency demonstrated across samples and bulk lots?
- Can the supplier support both powder and custom solution supply?
- Does the supplier avoid using the Greyverse™ trademark for generic material?
- Does the supplier offer formulation and technical support for hair-care applications?
FAQ
What should B2B buyers verify before ordering PTP20 powder or solution?
Buyers should confirm peptide identity, terminal form, active-content basis, batch-specific analytical documentation, supplied form and carrier composition where applicable. Samples should be evaluated against the intended formulation before scale-up. For powder supply with batch documentation, see the Palmitoyl Tetrapeptide-20 manufacturer in China product page.
Is powder more economical than solution?
It depends on the active basis. Powder usually avoids carrier and shipping costs and often delivers more active peptide per unit weight, but it requires weighing capability and formulation work. Solution reduces handling effort but may carry a much higher cost per gram of active peptide. Compare on cost per gram of active peptide, never on price per kilogram of the two forms.
How is active peptide concentration verified?
By the peptide assay on an active basis from the batch COA, supported by HPLC purity data and an MS identity report. HPLC area purity and assay measure different attributes and should not be treated as interchangeable values.
Can powder replace a branded PTP20 complex directly?
No. A branded complex such as Greyverse™ is a specific commercial system with its own INCI, carrier and data package; a generic Palmitoyl Tetrapeptide-20 powder is a different material. Replacement requires confirming peptide identity, terminal form, active concentration and the finished-formula behavior - not an equal-weight swap.
What packaging is suitable for bulk supply?
Common B2B options include sealed foil bags and drums for powder, with cool, dry and light-protected storage as recommended in the supplier's TDS. Solutions require packaging suited to the carrier and preservative system. Confirm the exact packaging and storage guidance for the supplied material.
References
- Almeida Scalvino S, et al. Efficacy of an agonist of α-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation. International Journal of Cosmetic Science. 2018;40(5):516–524.
- PubMed – Palmitoyl Tetrapeptide-20 hair pigmentation study, PMID 30222197.
- COSMILE Europe – Palmitoyl Tetrapeptide-20 and Palmitoyl Tetrapeptide-20 Amide cosmetic ingredient listings.
- Clariant / Lucas Meyer Cosmetics – Greyverse™ product information (Hair & Scalp Care; INCI: Glycerin (and) Water (and) Palmitoyl Tetrapeptide-20 Amide).
Looking for Palmitoyl Tetrapeptide-20 powder or solution for cosmetic formulation research? HDM Biotech provides batch-specific COA, assay documentation, sample support and bulk supply options according to the confirmed product specification. Contact HDM Biotech for current specifications and quotations.